Walleye Capital’s SeaStar Medical Warrant ICUCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-145,109
Closed -$6.28K – 5156
2024
Q3
$6.28K Hold
145,109
– – ﹤0.01% 4970
2024
Q2
$7.84K Hold
145,109
– – ﹤0.01% 5267
2024
Q1
$21.2K Sell
145,109
-43,191
-23% -$5.12K ﹤0.01% 4911
2023
Q4
$5.72K Hold
188,300
– – ﹤0.01% 4637
2023
Q3
$2.66K Hold
188,300
– – ﹤0.01% 4684
2023
Q2
$6.87K Hold
188,300
– – ﹤0.01% 3974
2023
Q1
$16K Sell
188,300
-20,100
-10% -$2.2K ﹤0.01% 3449
2022
Q4
$18.8K Hold
208,400
– – ﹤0.01% 2673
2022
Q3
$15K Hold
208,400
– – ﹤0.01% 2766
2022
Q2
$23K Sell
208,400
-1,200
-0.6% -$174 ﹤0.01% 1886
2022
Q1
$43K Sell
209,600
-300
-0.1% -$80 ﹤0.01% 1852
2021
Q4
$90K Buy
+209,900
New +$105K ﹤0.01% 1708

Other funds holding ICUCW

Walleye Capital's ICUCW Position: Q4 2024 in Review

Walleye Capital sold out of SeaStar Medical Warrant (ICUCW) in Q4 2024, closing a stake of 145,109 shares — an estimated $6.28K sold.

Walleye Capital first reported a position in ICUCW in Q4 2021 and held it in 12 quarters. The position peaked at $90K in Q4 2021. 13 funds tracked by Wall St. Rank hold ICUCW as of Q4 2024.

  • Walleye Capital reported no remaining SeaStar Medical Warrant position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 145,109 SeaStar Medical Warrant shares in Q4 2024, an estimated $6.28K.
  • Walleye Capital first reported a position in SeaStar Medical Warrant in Q4 2021 and held it in 12 quarters.
  • Walleye Capital's SeaStar Medical Warrant position peaked at $90K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held SeaStar Medical Warrant as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.